BIIE-0246 is a potent, non-peptide, highly selective antagonist of the neuropeptide Y (NPY) Y2 receptor (IC50 = 15 nM); it is used in research to investigate the physiological and pathological roles of NPY Y2 receptors, particularly in the regulation of body weight, adiposity, and cholesterol metabolism; it promotes body weight gain in both wild-type and NPY-deficient mice under normal and diet-induced obesity (DIO) conditions, with differential effects on fat mass and lean mass depending on genotype; it inhibits fat mass gain in DIO-NPY mice and modulates the relationship between cholesterol levels and body fat mass.